CALR c.251T>G ;(p.F84C)

Variant ID: 19-13050299-T-G

NM_004343.3(CALR):c.251T>G;(p.F84C)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma.

Nature Communications
Vo, Josh N JN; Wu, Yi-Mi YM; Mishler, Jeanmarie J; Hall, Sarah S; Mannan, Rahul R; Wang, Lisha L; Ning, Yu Y; Zhou, Jin J; Hopkins, Alexander C AC; Estill, James C JC; Chan, Wallace K B WKB; Yesil, Jennifer J; Cao, Xuhong X; Rao, Arvind A; Tsodikov, Alexander A; Talpaz, Moshe M; Cole, Craig E CE; Ye, Jing C JC; , ; Bergsagel, P Leif PL; Auclair, Daniel D; Cho, Hearn Jay HJ; Robinson, Dan R DR; Chinnaiyan, Arul M AM
Publication Date: 2022-06-29

Variant appearance in text: CALR: 251T>G; Phe84Cys
PubMed Link: 35768438
Variant Present in the following documents:
  • 41467_2022_31430_MOESM4_ESM.xlsx, sheet 1
View BVdb publication page



HPV transcript expression affects cervical cancer response to chemoradiation.

Jci Insight
Ruiz, Fiona J FJ; Inkman, Matthew M; Rashmi, Ramachandran R; Muhammad, Naoshad N; Gabriel, Nishanth N; Miller, Christopher A CA; McLellan, Michael D MD; Goldstein, Michael M; Markovina, Stephanie S; Grigsby, Perry W PW; Zhang, Jin J; Schwarz, Julie K JK
Publication Date: 2021-08-23

Variant appearance in text: CRT: F84C
PubMed Link: 34255749
Variant Present in the following documents:
  • Main text
View BVdb publication page